Compare KeyCorp (KEY) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KeyCorp vs Stryker Corporation — how do they compare? KeyCorp trades at $19.97 (market cap $21.45B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 5× KeyCorp's market cap, and KeyCorp pays the higher dividend (4.08%). Which is the better fit depends on your goals — on Pluang, investors hold KeyCorp for 66 Days and Stryker Corporation for 21 Days on average.
| KEY | SYK | |
|---|---|---|
Market Cap | $21.45B | $106.24B |
Volume | 19,450,846 | 2,982,001 |
Sector | Financials | Health |
52-Week High | $23.99 | $388.35 |
52-Week Low | $16.78 | $269.75 |
Typical Hold Time | 66 Days | 21 Days |
Enterprise Value | $34.63B | $117.70B |
Dividend Yield | 4.08% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KeyCorp (KEY) trades at $20.1, up 1.36% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows strong fundamentals with a P/E of 11.75, net income margin of 26.72%, and three consecutive quarterly EPS beats. Recent news includes a prime rate hike to 7.00% and executive appointments, while the dividend remains frozen.
The outlook is mixed: analyst consensus is bullish with a $25.00 price target, but technical weakness and competitive dividend pressures pose risks. Revenue growth and share buybacks support upside, yet interest rate sensitivity and margin pressures require monitoring for sustained performance.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
